×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
NovaBay Pharmaceuticals (NBY) Shows Fast-paced Momentum But Is Still a Bargain Stock
Yahoo Finance UK
NovaBay Pharmaceuticals (NBY) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors...
15 hours ago
NovaBay Pharmaceuticals Stock Is Up 50%: What's Going On? - NovaBay Pharmaceuticals (AMEX:NBY)
Benzinga
NovaBay Pharmaceuticals shares are trading higher by 50% Monday afternoon. The marked move higher comes despite a lack of company-specific...
1 day ago
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
Vision Monday
EMERYVILLE, Calif.—NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) reported financial results for the three and 12 months ended December...
1 month ago
NBY Stock Earnings: NovaBay Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
MSN
NBY stock results show that NovaBay Pharmaceuticals beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
1 week ago
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European ...
Yahoo Finance
EMERYVILLE, CA and BOULDER, CO / ACCESSWIRE / January 9, 2024 / NovaBay Pharmaceuticals, Inc. (NYSE American:NBY) and Sonoma Pharmaceuticals...
4 months ago
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decline in Short Interest
Defense World
Read NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decline in Short Interest at Defense World.
1 week ago
NovaBay Pharmaceuticals introduces optic allograft in US
Medical Device Network
NovaBay Pharmaceuticals has commercially introduced its optic Avenova Allograft for eyecare professionals in the US.
8 months ago
Facing the Fallout: The Consequences of Novabay Pharmaceuticals' Potential Delisting from NYSE American ...
Tipranks
Novabay Pharmaceuticals (NBY) has disclosed a new risk, in the Share Price & Shareholder Rights category. Should Novabay Pharmaceuticals' common stock be...
1 week ago
NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results
Vision Monday
EMERYVILLE, Calif.—NovaBay Pharmaceuticals, Inc., a developer of eyecare, skin care and wound care products, has reported its financial...
1 week ago
Earnings call: NovaBay reports record Avenova sales, eyes dry eye market
Investing.com
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) has reported a significant increase in sales for its Avenova line of products,...
1 week ago